BPC-157 20mg

BPC-157 20mg Overview

BPC-157 (Body Protection Compound 157) is a synthetic pentadecapeptide consisting of 15 amino acids. It has been investigated extensively in preclinical research, particularly in laboratory models involving tissue response, connective tissue, gastrointestinal systems and biological repair processes.

The compound has attracted research interest because of its stability compared with many peptides of a similar size. Published scientific literature examining BPC-157 is predominantly preclinical, consisting mainly of laboratory and animal studies rather than established human clinical trials.

This 20mg presentation provides a higher quantity of the same BPC-157 research peptide supplied in our 10mg vial. Interlink Peptides supplies BPC-157 20mg as a lyophilised preparation intended strictly for laboratory research applications.

Also available as a BPC-157 10mg research peptide

Technical Specification

Compound: BPC-157 (Body Protection Compound 157)
Quantity: 1 × 20mg vial
Form: Lyophilised powder
Peptide length: 15 amino acids
CAS Number: 137525-51-0
Molecular weight: Approximately 1,419 Da
Storage: −20 °C in lyophilised form
After reconstitution: Store refrigerated at 2–8 °C
Certificate of Analysis: Available where applicable

Research Background

BPC-157 has been investigated across a range of preclinical research models. A substantial area of published research concerns connective tissue and tissue-remodelling processes, including experimental models examining tendons, ligaments, muscle and other tissues.

Additional studies have investigated BPC-157 in gastrointestinal research, vascular models and pathways associated with nitric oxide. Its research history is closely associated with gastrointestinal investigation because the peptide sequence was identified from a larger protein associated with gastric juice.

The current evidence base should be interpreted appropriately. Most published BPC-157 research consists of in-vitro and animal studies, and human clinical evidence remains limited. Findings from preclinical models should therefore not be assumed to demonstrate effects in humans.

BPC-157 is also included on the World Anti-Doping Agency Prohibited List. This may be relevant to researchers conducting work connected with competitive sport or anti-doping research.

Interlink Peptides supplies BPC-157 UK research products strictly for laboratory investigation and does not provide guidance regarding human administration.

Shelf Life & Storage

When stored as a lyophilised powder, keep the product at approximately −20°C, protected from light and moisture.

Once mixed with water, the solution should be stored at refrigerator temperatures of approximately 2–8°C.

Avoid repeated freeze-thaw cycles and follow appropriate laboratory handling procedures.

Quality & Testing

Certificate of Analysis (COA) information is available where applicable to provide batch-specific analytical information.

Products should always be assessed against the information contained within the relevant batch documentation.

Explore our full range of research peptides for laboratory research applications.

Research Use Only

Interlink Peptides supplies BPC-157 20mg strictly for in-vitro laboratory and scientific research purposes.

This product is not intended for human or animal consumption, medical treatment, therapeutic use or clinical application. It has not been evaluated or approved by the MHRA for such purposes.

We do not provide dosing or administration guidance.